Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bio-Rad Laboratories, Inc. Class A Common Stock
(NY:
BIO
)
279.99
+32.46 (+13.11%)
Streaming Delayed Price
Updated: 2:46 PM EDT, May 18, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Bio-Rad Laboratories, Inc. Class A Common Stock
< Previous
1
2
3
4
Next >
Bio-Rad to Participate in Upcoming Investor Conferences
May 08, 2026
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports First-Quarter 2026 Financial Results
April 30, 2026
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026
April 16, 2026
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results
February 12, 2026
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026
January 29, 2026
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 44th Annual Healthcare Conference
January 06, 2026
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Third-Quarter 2025 Financial Results
October 29, 2025
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025
October 16, 2025
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Laboratories, Inc. Co-Founder and Director Emeritus Alice Schwartz Passes Away
September 29, 2025
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad's Management to Participate in Upcoming Investor Conferences
August 25, 2025
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025
August 01, 2025
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Second-Quarter 2025 Financial Results
July 31, 2025
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations
July 28, 2025
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025
July 17, 2025
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform Rollout
July 07, 2025
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad’s Management to Host Investor Meetings During Jefferies Global Healthcare Conference
May 29, 2025
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference
May 12, 2025
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports First-Quarter 2025 Financial Results
May 01, 2025
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
April 15, 2025
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types
April 23, 2025
Aggregate analysis of eight clinical trials of patients with advanced non-small cell lung cancer (aNSCLC) was supported by Biodesix, using Bio-Rad Droplet Digital™ PCR technology
From
Biodesix, Inc.
Via
GlobeNewswire
Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results
February 13, 2025
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies
February 13, 2025
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025
January 27, 2025
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests
January 08, 2025
From
Geneoscopy, Inc.
Via
Business Wire
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference
January 02, 2025
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference
November 21, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference
October 31, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Third-Quarter 2024 Financial Results
October 30, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024
October 14, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
S&P 500 Shake-Up: New Entrants Driving Market Momentum
September 24, 2024
The quarterly rebalancing of the S&P 500 reflects market capitalization and performance shifts, highlighting growth and challenges in multiple sectors.
Via
MarketBeat
Topics
Artificial Intelligence
Stocks
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
